Aarti Pharmalabs Ltd - 543748 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Anushakti Enterprise Pvt Ltd Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication regarding completion of dispatch of Annual Report FY2022-23 along with the Notice of 4th AGM to the Shareholders of the Company Aarti Pharmalabs Ltd - 543748 - Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Report for the Financial Year 2022-23 Aarti Pharmalabs Ltd - 543748 - Notice Of The 4Th AGM - Thursday, September 14, 2023
Notice of the 4th AGM to be held on Thursday, September 14, 2023 at 11:00 a.m. (IST) through VC/ OAVM Aarti Pharmalabs Ltd - 543748 - Reg. 34 (1) Annual Report.
Annual Report for the Financial Year 2022-23. Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement - 4th Annual General Meeting Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Earnings Conference Call held on August 10, 2023 on the Q1 FY24 Results Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of Investors/ Analyst Quarterly Earnings Call on the Financial Results of the Company for the Quarter ended June 30, 2023. Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Investor Presentation
Q1 FY24 Results Presentation of the Company Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Analysts/Investors call.